[HTML] springer.comFull View

[HTML][HTML] Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen… - Respiratory …, 2016 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …
被引用次数：151 相关文章
[PDF] core.ac.uk

[PDF][PDF] Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen, E Lappi-Blanco… - 2016 - core.ac.uk
Background: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …
[PDF] cyberleninka.org

[PDF][PDF] Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen, E Lappi-Blanco… - 2016 - cyberleninka.org
Background: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen… - Respiratory …, 2016 - infona.pl
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen, E Lappi-Blanco… - tspace.library.utoronto.ca
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …
[PDF] researchgate.net

[PDF][PDF] Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen, E Lappi-Blanco… - 2016 - researchgate.net
Background: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …
[HTML] biomedcentral.com

[HTML][HTML] Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola… - Respiratory …, 2016 - respiratory-research.biomedcentral …
Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor prognosis.
Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently two drugs …

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.

ST Lehtonen, A Veijola, H Karvonen… - Respiratory …, 2016 - europepmc.org
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …
[HTML] nih.gov

[HTML][HTML] Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen… - Respiratory …, 2016 - ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

ST Lehtonen, A Veijola, H Karvonen… - Respiratory …, 2016 - go.gale.com
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor
prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently …